Key words: acute phase protein; C-reactive protein; diagnosis; rejection; renal transplantation; serum Background. Early diagnosis of acute rejection after renal transplantation is important. There is evidence amyloid A protein that measurement of the acute phase proteins, C-reactive protein (CRP) and serum amyloid A protein (SAA) is helpful.
Introduction
Methods. In 64 consecutive patients, CRP was measured in a routine clinical system ( Technicon RA1000, Effective management of patients receiving renal alloBayer) and SAA in a new sensitive automated immunografts requires early recognition and adequate treatassay on the Abbott IM x instrument, daily or on ment of rejection episodes. Apart from direct alternate days for 30 days after renal transplantation.
monitoring of renal function, a variety of putative Results. Patients all received triple immunosuppression markers of rejection have been evaluated in serum and with cyclosporin, azathioprine, and prednisolone and urine, but none is both highly specific and highly all mounted a post-surgical acute phase response of sensitive. Nevertheless there is substantial evidence that SAA, but the CRP response was reduced or absent.
the serum concentrations of the highly sensitive major Serum creatinine rose significantly in 36 patients, leadacute phase proteins [1] , C-reactive protein (CRP) ing to treatment for first rejection. Thirty of these [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] and serum amyloid A protein (SAA) [14] [15] [16] [17] [18] [19] [20] [21] , episodes were confirmed rejection, three were definitely can provide useful information in this context. These not and three were uncertain. SAA, normally observations were first made with CRP before the <10 mg/l, rose to more than 100 mg/l in all episodes widespread introduction of cyclosporin. Subsequently except when rejection was definitely absent. In six cases it has become clear that standard immunosuppressive SAA rose above 100 mg/l 1-3 days before the rise in therapy with cyclosporin and prednisolone markedly creatinine leading to antirejection therapy, and only suppresses the acute phase response of this protein to twice did creatinine rise 1 day before SAA. In contrast, transplantation surgery and to acute rejection [11, 22] , CRP responses to rejection were modest or absent. In although not the response to intercurrent infection. In four patients there were SAA and CRP responses contrast the SAA response to transplant surgery still unrelated to rejection, three associated with intercuroccurs during cyclosporin and steroid treatment, and rent infection and one with administration of antithe responses to rejection and infection are apparently lymphocyte globulin. There were also two unexplained unimpaired [14] [15] [16] [17] [18] [19] [20] [21] . isolated spikes of SAA.
The acute phase response is a non-specific phenomConclusions. SAA is a sensitive marker of acute renal enon induced by almost all forms of tissue damage, allograft rejection. It is not specific, but the differential inflammation and infection, and although both CRP behaviour of CRP in patients receiving cyclosporin and SAA are exquisitely sensitive and rapid reactants helps to distinguish infection from rejection.
covering extremely wide dynamic ranges, their serum Availability of rapid assays for these analytes should levels can never be diagnostic on their own [1, 23] . facilitate management of renal allograft recipients.
They must be interpreted in the context of the full clinical picture and can then provide invaluable information for both diagnosis and management. In Correspondence and offprint requests to: Professor M. B. Pepys, the present study we have used a new, rapid, automated patient. Rejection episodes requiring treatment were identiresponse to episodes of renal allograft rejection. The fied clinically by a rise of 20% or more in serum creatinine contrast between specific failure of the CRP response compared to the preceding one or two measurements, usually to rejection in these cyclosporin-treated patients and combined with a fall in urine output. The grafts were preservation of the response of both proteins to infec-examined by ultrasound to exclude urinary obstruction and tion enhances the value of frequent routine measure-duplex Doppler did not reveal any renal transplant artery ment of both SAA and CRP.
stenosis. Exposure to nephrotoxic medications was evaluated and infection excluded by clinical and microbiological investigation. Cyclosporin nephrotoxicity was not suspected on
Subjects and methods
clinical grounds to be the cause of increased serum creatinine in any case, and in no patient was cyclosporin dosage reduced during antirejection treatment. Despite this, and despite even Serum samples (n=1021) obtained daily or on alternate days increased doses of cyclosporin in some cases, the rise in for the first 30 days after transplantation from 64 consecuserum creatinine was always reversed by antirejection tive patients receiving renal allografts during 5 months in therapy. This is strong clinical evidence against acute cyclo-1992 were stored frozen at −70°C and assayed in single sporin toxicity as the cause of rising serum creatinine in batch at the end of the study. SAA was determined by those rejection episodes that were not confirmed by biopsy. monoclonal-polyclonal microparticle enzyme immunoassay Fifteen episodes of rejection were also verified by biopsy, on the Abbott IM x instrument [24] . Using this method in taken with an ultrasound guided automatic gun biopsy 105 healthy normal adults, the mean (SD) SAA value was system using 18-G needles ( Biopty, Bard, Covington, GA, 3.7 ( 3.6) mg/l, the median (range) was 3.0 ( 0.7-26.4) mg/l; USA) and immediately fixed, embedded, and stained by 82% of values were below 5 mg/l and 96% below 10 mg/l standard techniques before independent evaluation by at [ 24] . CRP was measured by the Technicon RA1000 immunotleast two renal pathologists. Results were reported as either urbidimetric method, which has a lower limit of sensitivity negative or positive for rejection; the Banff classification was of 2 mg/l. However, the median normal level of CRP in not used at that time. First rejection episodes presented here healthy adults is 0.8 mg/l with 90% of values being less than were treated with divided daily doses of methylprednisolone 3 mg/l and 99% less than 10 mg/l [25 ] . In serial studies of (0.5 g, 0.25 g, 0.25 g, and 0.25 g) for 4 or 5 days. Rejection healthy subjects it is clear that low levels of both CRP and unresponsive to steroids was treated with monoclonal anti-SAA, close to the medians cited above, are actually normal, T-cell antibody (OKT3) or polyclonal antilymphocyte whilst higher values occur rarely and sporadically in most globulin (ATG). individuals ( M. B. Pepys, J. R. Gallimore and J. Stuart, unpublished observations) and almost certainly reflect the sensitivity of the response of these reactants to minor or subclinical intercurrent events.
Results
Demographic and clinical details of the patients studied are shown in Table 1 . All recipients had primary renal graft A typical postoperative acute-phase response of SAA function. The immunosuppression regimen consisted of is shown in Figure 1 . The peak was usually on day 2 cyclosporin, azathioprine and prednisolone. Cyclosporin but there was enormous variation between individuals dosage was adjusted in order to obtain whole blood levels in the values attained (45-1829 mg/l ). In marked of about 300-400 ng/ml in the first month after transplantacontrast, although some patients mounted an acutetion. On the day of transplantation all patients received 0.5 g phase response of CRP, in many there was only a methylprednisolone intravenously. After transplantation the oral daily dose of prednisolone was 80 mg, reducing modest or even no rise at all in CRP concentration.
by 10 mg/day down to 20 mg/day during the first month.
Rising serum creatinine considered to represent a Initial azathioprine dosage was 2 mg/kg/day tapered to first rejection episode, and consequently treated as 1 mg/kg/day over a few weeks. All patients received co-trimoxazole prophylaxis. Induction therapy with anti-Tcell antibody (OKT3) was given to one HLA-sensitized 44/20 Previous CAPD (n) 5 Previous haemodialysis (n) 3 5 Predialysis transplantation (n) 1 7 Retransplants (n) 7 Combined pancreas/kidney graft (n) 4 Simultaneous nephrectomy (n) 1 0 Living donor graft (n) 2 9 Cadaver donor graft (n) 3 5 Cold ischaemia time (cadaver 14 ( 4-28) Fig. 1 . Time of peak postoperative SAA value after renal transdonor grafts) ( h) plantation surgery in the 44 patients for whom data were available.
such, was observed in 36 patients (56%). In three of these cases it subsequently became clear that there had been no rejection and in none of these was there any increase in SAA. However, there was an acute phase response of SAA in association with all the other episodes (Figure 2a-c) . Measurements of SAA and serum creatinine were available the day before and on the day of rejection treatment in 15 episodes of first rejection in 15 patients. The median (range) SAA value rose from 72 ( 19-1049) mg/l to 201 (135-1686) mg/l, whereas the serum creatinine levels in the same samples increased from 171 (131-182 ) mmol/l to 232 ( 151-411) mmol/l. The relative increase was significantly higher for SAA than for creatinine (P<0.001).
Although there was sometimes a CRP acute-phase response related to rejection, it was often minimal and/or entirely absent (Figure 2a-c) .
In six cases the rise in SAA preceded the rise in serum creatinine by 1-4 days, and thus predicted the rejection episode ( Figure 3a,b) . Also in five of these cases the peak of the SAA acute phase response to rejection occurred 1 or 2 days before rather than on the day of starting antirejection therapy (Figure 3a,b) . Only twice did the rise in serum creatinine precede that of SAA.
When acute rejection occurred very soon after transplantation the corresponding SAA acute-phase response was masked by the normal postoperative peak as shown in Figure 4 . This same case also illustrates the acute-phase response that was observed in all patients treated with antilymphocyte globulin. Furthermore, although dwarfed in magnitude by the enormous SAA response, this individual did mount a CRP response, at least to surgery and to the injection of antithymocyte globulin.
Apart from three unexplained isolated spikes of SAA, there were four acute-phase responses unrelated to rejection episodes. Three of these were clearly caused by intercurrent microbial infections and the other by induction therapy with OKT3 in a patient receiving a second transplant. In all of these four cases there was a vigorous response of CRP as well as SAA.
In the study as a whole, SAA concentrations above 100 mg/l were observed in 37 patients associated with 33 rejection episodes, giving a positive predictive value for the test at this level of 0.89. Among 27 patient episodes in which there was no rejection, there were no elevations of SAA, giving a negative predictive value of 1.0. The negative predictive value of a <20% rise in serum creatinine was, obviously, also 1.0, as this was the primary criterion used to identify rejection, whilst the positive predictive value was 0.92 based on In this study, episodes of rejection were diagnosed and creatinine that triggered antirejection therapy but it is minimized by the scale of the figure required to accommodate the extreme SAA treated primarily on clinical grounds and, when impairlevels. (c ), Typical, although modest, SAA response to a rejection ment of renal function was reversed by antirejection episode together with a minimal CRP response. therapy, biopsies were not routinely taken. This was Fig. 4 . SAA and CRP responses following renal transplantation. A first rejection episode occurred very early after transplantation and the associated SAA response was masked by the postoperative peak. Subsequently the SAA rose well before a second episode of rejection, and there was then a further SAA response to antirejection therapy with antithymocyte globulin. There was a major CRP response in relation to surgery and/or the first rejection episode, no CRP response to the second rejection episode, and a further response to administration of antithymocyte globulin.
greater than that of the serum creatinine concentration. In contrast the response of CRP, which in all other clinical circumstances is an exquisitely sensitive acutephase reactant [23] , was blunted and frequently completely absent, not only in relation to rejection but also following the usually potent stimulus of surgical trauma. This suppression of the CRP response reflects There have in the past been claims that the SAA creatinine and had then fallen, although still remaining very high, response in general is more sensitive than that of CRP, on the day antirejection treatment was started. There was no CRP but these have largely been based on the fact that response to this rejection episode.
sensitive immunoassays for SAA covering its whole range have been compared with routine clinical assays for CRP with lower detection limits of 5 mg/l or the standard practice in our Department at that time and we have assessed SAA and C-reactive protein greater. This is very misleading because the normal range for CRP is actually 0.05-3.0 mg/l [25] , and if measurements in this normal clinical setting. However, biopsies were taken in almost half the clinically dia-suitably sensitive CRP assays are used similar or even more useful clinical information can be derived from gnosed rejection episodes and always confirmed the diagnosis. Data from the biopsied and non-biopsied the CRP values [26 ] . This may in part be because the high sensitivity and dramatic dynamic range of SAA patients were the same and the results from all the cases were therefore evaluated as a whole.
production lead to more 'noise' in the system. Nevertheless the original observation of Maury et al. The present results confirm and extend the substantial body of earlier work showing that SAA is a highly that renal allograft rejection is a particularly powerful stimulus for SAA production [14-18 ] has been abundsensitive acute phase reactant in patients undergoing acute renal allograft rejection [14] [15] [16] [17] [18] [19] [20] [21] . SAA levels rose antly confirmed, and the distinction from CRP has been enhanced since the introduction of cyclosporin dramatically in association with all rejection episodes and in a significant proportion of cases they rose 1 or that so effectively suppresses CRP production in this context. Indeed this enables measurement of these two more days before the start of antirejection therapy. Not surprisingly for the product of such a highly acute phase proteins to provide improved discrimination, since both of them respond sensitively to infecregulated gene, the dynamic range of SAA was much Serum amyloid A protein is a useful marker of renal allograft rejection 165 2. White J, Meyer E, Hardy MA. Prediction of onset and termination, the major differential diagnosis, but only SAA tion of renal allograft rejection by serum levels of C-reactive responds well to graft rejection. protein. Transplant Proc 1981; 13: 682-684 The acute-phase response is non-specific and meas- 1987; 19: 1683-1685 excluded the specificity is 80-90% at this level. 
